Emergent BioSolutions Inc. (EBS)
NYSE: EBS · IEX Real-Time Price · USD
11.20
0.00 (0.00%)
Jul 22, 2024, 10:25 AM EDT - Market open
Emergent BioSolutions Employees
Emergent BioSolutions had 1,600 employees as of December 31, 2023. The number of employees decreased by 900 or -36.00% compared to the previous year.
Employees
1,600
Change (1Y)
-900
Growth (1Y)
-36.00%
Revenue / Employee
$740,875
Profits / Employee
-$353,250
Market Cap
574.85M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Varex Imaging | 2,400 |
Pharming Group | 382 |
Surmodics | 376 |
Verve Therapeutics | 255 |
Allogene Therapeutics | 233 |
Annexon | 71 |
GH Research | 49 |
Larimar Therapeutics | 42 |
EBS News
- 13 days ago - Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan - GlobeNewsWire
- 13 days ago - Emergent, J&J settle COVID vaccine supply deal dispute - Reuters
- 19 days ago - Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? - Benzinga
- 20 days ago - Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products - GlobeNewsWire
- 20 days ago - Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day - GlobeNewsWire
- 2 months ago - Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 - GlobeNewsWire